The US is reviewing Benchmark's investment into Chinese AI startup Manus
Manus AI is one of the hottest AI agent startups around, recently raising $75 million at a half-billion-dollar valuation in a round led by Benchmark.
But two unnamed sources told Semafor that the investment is now under review by the U.S. Treasury Department over its compliance with 2023 restrictions on investing in Chinese companies.
Benchmark's lawyers cleared the investment because Manus isn't technically developing its own AI models, but is instead a 'wrapper' around existing ones, Semafor reported.
Those lawyers also concluded Manus is not China-based since it's incorporated in the Cayman Islands. (That's a common structure used by Chinese companies, like Alibaba, to access foreign capital.)
Benchmark has attracted criticism for its Manus investment from Founders Fund partner Delian Asparouhov, who posted on X 'wow, actions have consequences?'.
Benchmark, Manus, and Treasury didn't immediately respond to requests for comment.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
US and Chinese officials will resume trade talks in London on Monday, Trump says
President Donald Trump announced Friday that US and Chinese officials will meet in London on Monday to discuss trade between the two nations. 'I am pleased to announce that Secretary of the Treasury Scott Bessent, Secretary of Commerce Howard Lutnick, and United States Trade Representative, Ambassador Jamieson Greer, will be meeting in London on Monday, June 9, 2025, with Representatives of China, with reference to the Trade Deal,' the president wrote in a post on Truth Social. The announcement comes after Trump and his Chinese counterpart Xi Jinping spoke for 90 minutes on Thursday. After the phone call, the US president said he was encouraged that ongoing trade tensions could soon be resolved. The last talks between the Trump administration and their Chinese counterparts, held on May 12 in Geneva, represented a major turning point for the global trade war. Delegates from China and the United States announced they would significantly roll back their historically high tariffs on one another. Markets rallied, Wall Street banks curtailed their recession forecasts, and moribund USconsumer confidence rebounded significantly. That marked a significant change from April, when tensions ran so high that trade between the United States and China came to an effective halt. The 145% tariffs on most Chinese imported goods made the math impossible for American businesses to buy virtually anything from China, America's second-largest trading partner. But since then, tensions had re-escalated. Trump on Wednesday said in a Truth Social post that Chinese leader Xi Jinping was 'extremely hard to make a deal with.' Trade talks have stalled, Bessent said, apparently frustrating Trump. Last week, Trump posted on social media that China 'TOTALLY VIOLATED ITS AGREEMENT WITH US.' Trump said that he made a 'fast deal' with China to 'save them from what I thought was going to be a very bad situation.' He added: 'So much for being Mr. NICE GUY!' The Trump administration had expected China to lift restrictions on rare earth materials that are critical components for a wide range of electronics, but China has largely refused, causing intense displeasure inside the Trump administration and prompting a recent series of measures to be imposed on the country three administration officials told CNN last week. For example, the White House warned US companies against using AI chips made by China's national tech champion Huawei. It stopped US companies from selling to China software that is used to design semiconductors. And the US State Department announced it would 'aggressively revoke visas' for some Chinese students in in turn, has accused the United States of 'provoking new economic and trade frictions.' 'The United States has been unilaterally provoking new economic and trade frictions, exacerbating the uncertainty and instability of bilateral economic and trade relations,' the Chinese Commerce Ministry said Sunday. In the meantime, Treasury Secretary Scott Bessent, America's chief negotiator in the détente with China, said talks with China had stalled. But Trump and and Chinese leader Xi Jinping held a long-awaited phone call Thursday, which appears to have lowered the temperature a bit. The New York Times on Friday reported China has issued some licenses for rare earths, although the market is hardly back open. The talks in the UK are significant, and much is riding on their success – US economic growth remains steady but there are signs of cracking. And no one wants to return to April's standoff, which threatened to plunge the global economy into a stocks, which had rallied earlier in the day on a strong jobs report, rose a bit higher after Trump's Truth Social message about the resumed talks. The Dow was up 450 points, or 1.1%. The S&P 500 rose 1.2%, and the Nasdaq was 1.3% higher.
Yahoo
12 minutes ago
- Yahoo
Trump reluctant to confront China over support for Russia's war against Ukraine, Bloomberg reports
U.S. President Donald Trump is pulling back from pressuring China over its support for Russia's war effort, instead prioritizing other aspects of the U.S.-China relationship, U.S. and European officials familiar with internal discussions told Bloomberg. These officials, speaking anonymously, said that the administration has lowered the issue of Russia's war against Ukraine on its list of foreign policy priorities and is focusing on bilateral issues with Beijing, though they noted Trump could still shift course. The change in approach marks a departure from the long-held stance of the U.S. and its G7 partners, who have consistently called out China as a key enabler of Russia's war in Ukraine. In March, G7 foreign ministers condemned Beijing's support for Moscow and urged it to use its influence over Russian President Vladimir Putin to help end the war. However, Trump said that "nothing was discussed concerning Russia/Ukraine" during his recent call with Chinese President Xi Jinping. Officials suggest this pivot reflects Trump's desire to break with the foreign policy priorities of former President Joe Biden, who viewed relations with other governments largely through the lens of Russia's invasion of Ukraine. Instead, Trump's team is prioritizing issues like tariffs, technology restrictions, and rare earths. One official noted that Trump is reluctant to directly criticize China's role in aiding Russia while he continues talks with Putin aimed at brokering a ceasefire. At the same time, Trump ally Senator Lindsey Graham is pushing for new sanctions against Russia, including measures targeting Chinese and Indian purchases of discounted Russian oil. Graham's bill has gained over 80 co-sponsors in the Senate, signaling strong bipartisan support. U.S. officials have also expressed frustration at European countries that continue buying Russian energy while criticizing Beijing's exports to Moscow—exports that include dual-use components and sanctioned technologies used in weapons production. Despite Trump's current stance, the European Union has maintained public pressure on China, both through diplomatic channels and public statements. EU foreign policy chief Kaja Kallas recently accused Beijing of fueling Russia's war through dual-use exports. Moscow has continued to receive critical components from China, including drone parts, even as Beijing has restricted similar exports to Ukraine and the West. While the Biden administration and EU have sanctioned several Chinese firms involved in aiding Russia's military production, Trump has yet to impose any new penalties. Read also: 'Find and destroy' – how Ukraine's own Peaky Blinders mastered the art of bomber drones We've been working hard to bring you independent, locally-sourced news from Ukraine. Consider supporting the Kyiv Independent.
Yahoo
18 minutes ago
- Yahoo
LEADOPTIK Awarded Key Patents Across Three Continents
Strengthening Global IP Portfolio in Optical Imaging for Minimally Invasive Procedures SAN JOSE, Calif., June 6, 2025 /PRNewswire/ -- LEADOPTIK Inc., a Silicon Valley-based medical imaging company, today announced it has been awarded key patents for its proprietary optical probe across three continents: North America, Europe, and Asia. LEADOPTIK designs and manufactures optical probes for minimally invasive procedures, where two critical factors are essential: high-resolution imaging and a miniaturized form factor. High-resolution imaging enables real-time visualization of tissue microstructure, empowering clinicians with the insight needed to make more informed decisions—whether collecting biopsy samples, resecting tumor margins, or delivering therapies to targeted sites. Equally important is miniaturization. Space is at a premium during minimally invasive procedures, and LEADOPTIK's probe is designed with an exceptionally small footprint to navigate tight anatomical pathways without compromising performance. The company's innovation is powered by cutting-edge metasurface technology—flat optical components created through the fusion of nanofabrication and advanced optical design. Unlike traditional optics, metasurfaces enable ultra-thin, high-performance imaging systems that are ideal for integration into medical devices. These three newly granted patents underscore LEADOPTIK's leadership in medical imaging: U.S. Patent (#US11953698B1): Covers a novel device-level metasurface design that significantly extends imaging depth without sacrificing resolution. The patent was granted with 100% of its original claims—a testament to the novelty of LEADOPTIK's approach. European and Japanese Patents (PCT065237 & PCT029301): Protect both the current probe assembly method and alternative configurations that support expanded clinical applications. "Building robust and scalable medical devices is non-negotiable," said Reza Khorasaninejad, CEO and Co-founder of LEADOPTIK. "Our team has not only invented new optical designs but also developed novel methods of integrating them with semiconductor-grade manufacturing processes. These patents reflect our commitment to making next-generation imaging accessible, reliable, and globally protected." "Our intellectual property is the foundation of LEADOPTIK's competitive edge," said Dr. Jiang You, Co-Founder and VP of Medical Imaging. "These patents not only protect our unique optical architecture but also validate the deep technical innovation required to miniaturize high-resolution imaging. It's a major milestone that strengthens our ability to scale globally and expand into new clinical applications." About LEADOPTIK LEADOPTIK is a Silicon Valley-based company pioneering AI-enhanced real-time optical imaging at the point of biopsy. By integrating high-resolution microstructural visualization with emerging analytics, the LIA system bridges the gap between diagnosis, and therapy, supporting more precise and informed decision-making in interventional pulmonology and beyond. For more information, visit Media Contact:hello@ View original content: SOURCE LEADOPTIK Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
